Trulieve Cannabis Corp., Lemonade, Inc., Cresco Labs Inc. are at the top of this list of down trending small cap stocks.
Markets were up yesterday; Nasdaq ended the session at 11,500 after a 1.76% gain. S&P 500 closed the day at 4,060.43, having gained 1.1%.
More data out yesterday as United States New Home Sales (Dec) came out at 616,000, while a consensus of analysts was expecting 617,000.
What is a downtrend?
The perceived tendency of a price to move in a downward direction over time. A downtrend describes the price movement of a continously depreciative financial asset over a particular time frame. In a downtrend, each successive low and peak is lower than the ones found earlier in the trend. The downtrend is therefore composed of lower swing lows and lower swing highs.
| Trulieve Cannabis | continues a 17 day decline; retreats 1.11% yesterday
After setting a $6.05 – $6.44 range, Trulieve Cannabis Corp. closed the day 1.11% lower at $6.24. The leading CBD products developer has recovered almost all of its session losses after dipping down to $6.05 yesterday. Daily trading volume (493,231 shares) increased, making up 134% of the 21-day average (369,345).
Lemonade continues a 6 day downtrend; slumps 1.2% yesterday
After setting a $14.63 – $15.6 range, Lemonade closed the day 1.2% lower at $14.87. The NY-based insurance company has recovered almost all of its session losses after dipping down to $14.63 yesterday. Daily trading volume (1 million shares) increased, making up 100% of the 21-day average (1 million).
| Cresco Labs | continues a 6 day decline; falls 3.85% yesterday
Yesterday's session continued the recent downtrend: despite the risk-off mood, Cresco Labs was range-bound between $1.73 to $1.87 and settled at $1.75. After setting a $1.73 – $1.87 range, Cresco Labs closed the day 3.85% lower at $1.75. The day's trading volume totalled 555,781 shares — slightly under the 21-day average of 576,469.
The company's market cap currently stands at $534.57 million with an average daily volume of 576,469 shares. The consumer lifestyle brand developer is now trading 76.36% below the significant high of $7.7 it set around 11 months ago. Cresco Labs is forecasted to generate revenues of $210.48 million and EPS of $0.